Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer

BACKGROUND: The lipogenic enzyme fatty acid synthase (FAS) is up-regulated in a wide variety of cancers, and is considered a potential metabolic oncogene by virtue of its ability to enhance tumor cell survival. Inhibition of tumor FAS causes both cell cycle arrest and apoptosis, indicating FAS is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Knowles, Lynn M, Smith, Jeffrey W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913522/
https://www.ncbi.nlm.nih.gov/pubmed/17565694
http://dx.doi.org/10.1186/1471-2164-8-168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913522/
https://www.ncbi.nlm.nih.gov/pubmed/17565694
http://dx.doi.org/10.1186/1471-2164-8-168

Ejemplares similares